Skip to main content
. 2015 Apr 13;2015(4):CD008457. doi: 10.1002/14651858.CD008457.pub2

5. Research recommendations based on a gap in the evidence on chlorhexidine treatment for the prevention of dental caries in children and adolescents.

Core elements Issues to consider Status of research for this review
Evidence
 (E) What is the current state of evidence? A systematic review that identified eight RCTs matching the eligibility criteria, but were incompletely reported, had significant losses to follow‐up, and were assessed as at unclear or high risk of bias
Population
 (P) Diagnosis, disease stage, comorbidity, risk factor, sex, age, ethnic group, specific inclusion or exclusion criteria, clinical setting
  • Children ± 13 years permanent and primary dentition. High to moderate caries risk

  • History of previous caries experience (MS levels/caries screen assessment)

  • From low‐income (low/no fluoride) and high‐income countries

  • School and community setting


EXCLUDED
  • Participants with fixed orthodontic appliances

Intervention
 (I) Type, frequency, dose, duration, prognostic
 factor Chlorhexidine‐containing products:
  • Gels, toothpastes, varnishes, mouthrinses, chewing gums and sprays of different formulations, concentrations and application regimens


Administration minimum once over a period of 1 year
EXCLUDED
  • Combined interventions of chlorhexidine and fluoride


Compliance to be recorded
Comparison
 (C) Type, frequency, dose, duration, prognostic factor
  • Placebo, no intervention or routine care

  • Head‐to‐head comparisons: different chlorhexidine preparations, concentrations, frequency (single or multiple application) of use


EXCLUDED
  • Comparisons between chlorhexidine and fluoride interventions

  • Concomitant topical fluoride administration


Compliance to be recorded
Outcome
 (O) Which clinical or patient‐related outcomes will the researcher need to measure, improve, influence or accomplish?
 Which methods of measurement should be used? Dental caries (coronal)
 Diagnosis (at the dentine level) clinically/radiographically confirmed.
 Caries increment: change from baseline (D(M)FS/T, d(m)fs/t) index.
MS reductions in levels
 Pain, quality of life or patient satisfaction outcomes measured on a validated scale
Time Stamp
 (T) Date of literature search or recommendation 14 January 2014
Study Type What is the most appropriate study design to address the proposed question? RCT
 Methods: Concealment of allocation sequence 'Clear'
Blindness: Patients, carers, trialists, outcome assessors blind
Setting for administration: home or dental hospital/clinic
Setting for clinical outcome assessment: in dental hospital/clinic with appropriate length of follow‐up

(D(M)FS/T: decayed, missing and filled surfaces or teeth (permanent)
 d(m)fs/t): decayed, missing and filled surfaces or teeth (primary)
 MS: mutans streptococci
 RCT: randomised controlled trial